- $121.93bn
- $140.83bn
- £32.67bn
- 98
- 63
- 99
- 99
REG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Statement: Zantac (ranitidine) litigation
AnnouncementREG - GSK PLC - Statement: Zantac (ranitidine) litigation
AnnouncementREG - GSK PLC - FDA approves Arexvy for adults 50-59 at risk
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK Capital B.V. - Annual Financial Report
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - Unprecedented results in Jemperli trial continue
AnnouncementREG - GSK PLC - ASCO positive Blenrep DREAMM-8 trial results
AnnouncementREG - GSK PLC - Statement: Zantac (ranitidine) litigation
AnnouncementREG - Crism Therapeutics - Admission to Trading and First Day of Dealings
AnnouncementREG - GSK PLC - Statement: Zantac (ranitidine) litigation
AnnouncementREG - GSK PLC - Positive phase III asthma results for depemokimab
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - GSK completes sale of shares in Haleon plc
AnnouncementREG - GSK PLC - GSK announces intention to sell shares in Haleon
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Block listing Interim Review
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
Announcement